Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Sale | 2024-04-17 5:14 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.29 | $30,471 | 118,043 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:07 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-19 4:27 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $20.1 | $33,487 | 119,709 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 5:38 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.37 | $30,604 | 121,375 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:15 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 9,589 | $17.29 | $165,794 | 2,480,671 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 22,844 | $17.62 | $402,420 | 711,090 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:26 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.42 | $30,688 | 123,041 (Direct) | View |
| 2024-01-10 Sale | 2024-01-12 8:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:28 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 7,818 | $19.78 | $154,640 | 2,490,260 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 9,972 | $19.43 | $193,756 | 360,681 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 9,972 | $19.43 | $193,756 | 683,934 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:33 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 17,483 | $19.43 | $339,695 | 2,498,078 (Indirect Direct) | View |
| 2023-12-15 Sale | 2023-12-18 7:30 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $23.39 | $38,968 | 124,707 (Direct) | View |
| 2023-11-15 Sale | 2023-11-16 6:14 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $19.13 | $31,871 | 126,373 (Direct) | View |
| 2023-10-16 Sale | 2023-10-18 4:44 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $20.66 | $34,420 | 128,039 (Direct) | View |
| 2023-09-15 Sale | 2023-09-19 4:45 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $23.62 | $39,348 | 129,705 (Direct) | View |
| 2023-08-23 Sale | 2023-08-25 5:36 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,522 | $23.17 | $58,435 | 640,186 (Indirect Direct) | View |
| 2023-08-23 Sale | 2023-08-25 5:30 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,522 | $23.22 | $58,561 | 316,933 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:34 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,478 | $22.6 | $56,003 | 319,455 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:33 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,478 | $22.59 | $55,978 | 642,708 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:32 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,309 | $22.59 | $52,160 | 2,426,041 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:31 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,419 | $22.6 | $32,069 | 995,799 (Indirect Direct) | View |
| 2023-08-15 Sale | 2023-08-17 6:42 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $24.3 | $40,484 | 131,371 (Direct) | View |
| 2023-08-14 Sale | 2023-08-16 6:20 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,768 | $23.79 | $65,851 | 321,933 (Indirect Direct) | View |
| 2023-08-14 Sale | 2023-08-16 6:19 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,772 | $23.67 | $65,613 | 645,186 (Indirect Direct) | View |
| 2023-08-10 Sale | 2023-08-14 5:13 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,526 | $25.03 | $63,226 | 3,546,441 (Indirect Direct) | View |
| 2023-08-10 Sale | 2023-08-14 5:12 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,857 | $24.15 | $68,997 | 324,701 (Indirect Direct) | View |
| 2023-08-10 Sale | 2023-08-14 5:11 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,853 | $24.18 | $68,986 | 647,958 (Indirect Direct) | View |
| 2023-07-17 Sale | 2023-07-19 5:10 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 19,702 | $29.8 | $587,157 | 719,748 (Indirect Direct) | View |
| 2023-07-17 Sale | 2023-07-19 5:09 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $29.6 | $49,314 | 133,037 (Direct) | View |
| 2023-06-28 Sale | 2023-06-30 5:21 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $29.84 | $49,709 | 134,703 (Direct) | View |
| 2023-06-16 Sale | 2023-06-20 6:28 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 50,000 | $31.4 | $1,570,000 | 3,548,967 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-29 Gift | 2024-03-29 5:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0 | 2,440,671 (Indirect) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0 | 879,012 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0.68 | 879,012 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:57 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 214,880 | $0 | 855,066 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:57 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 214,880 | $0 | 531,813 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:56 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 358,080 | $0 | 2,784,121 (Direct) | View |
| 2023-08-10 Exercise | 2023-08-14 5:13 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,526 | $0 | 3,546,441 (Direct) | View |
| 2023-08-10 Exercise | 2023-08-14 5:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,526 | $0.68 | 3,546,441 (Indirect) | View |
| 2023-07-17 Exercise | 2023-07-19 5:10 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 10,000 | $5.28 | 719,748 (Indirect) | View |
| 2023-07-17 Exercise | 2023-07-19 5:10 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 10,000 | $0 | 719,748 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 6:28 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 50,000 | $0 | 3,548,967 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 6:28 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 50,000 | $0.68 | 3,548,967 (Indirect) | View |